Abstract:Abstract Background and Objectives: With the increasing need for clinicians to develop novel treatment strategies for the treatment of CVDs, the future lies in developing personalized nutrient recommendations based on an individual's needs. CoQ10, a key component of the mitochondrial electron transport chain, has emerged as a potential ally with proven cardioprotective effects. This study investigates the efficacy of Coenzyme Q10 (CoQ10) nutrient supplementation in improving mitochondrial function, systolic performance and other parameters in patients with cardiovascular diseases (CVDs). Methods: A systematic review and meta-analysis included data from PubMed, Embase, and the Cochrane Library up to January 2024. Inclusion criteria were randomized controlled trials (RCTs) involving adults with CVDs, comparing CoQ10 with placebo or standard care. Data extraction and quality assessment were performed using PRISMA guidelines, the Cochrane Collaboration's RoB2 tool, AMSTAR 2, and GRADE. Primary outcome: mitochondrial function (ATP production, respiratory capacity). Secondary outcome: systolic function (ejection fraction). Findings: From initial reference list of 46 selected studies, 22 were extracted presenting the encompassing a total sum of 11,372 subjects that were included in the meta-analysis with a total follow-up time ranging from 2 to 144 months (12 years). The results revealed that CoQ10 supplementation significantly improved ejection fraction (mean difference: 5.6%, 95% CI: 3.2% to 8.0%, p<0.001, I=25%). The I statistic for ejection fraction was 25%, indicating low heterogeneity among the studies included in the meta-analysis. Mitochondrial function showed increased ATP production (SMD: 0.82, 95% CI: 0.60 to 1.04, p<0.001, I=30%) and enhanced respiratory capacity (SMD: 0.75, 95% CI: 0.53 to 0.97, p<0.001, I=28%). The I statistics for ATP production and mitochondrial respiratory capacity were 30% and 28%, respectively, suggesting low to moderate heterogeneity among the included studies. Sensitivity analyses confirmed the robustness of the results, with consistent effect sizes and confidence intervals across both fixed-effect and random-effects models, and no significant changes upon excluding high-risk studies. Publication bias was low, as indicated by funnel plots and Egger's test (p=0.12). Limitations: Larger-scale RCTs are needed to confirm findings and determine the optimal dosage and duration of CoQ10 therapy. Conclusion: CoQ10 has demonstrated to improve mitochondrial function, systolic performance, and other important cardiovascular health parameters in CVD patients. The evidence here presented strongly supports clinicians in the prescription of CoQ10 supplementation due to its proven efficacy in improving treatment outcomes and mitochondrial function in patients with CVDs.

Coenzyme Q10 supplementation – In ageing and disease

Coenzyme Q10 Supplementation in Aging and Disease

Coenzyme Q10 – a literature review on supplementation in chronic disorders and the anti-aging process

Clinical aspects of coenzyme Q10: An update

Coenzyme Q10: A Ubiquitous Supplemental Enzyme Contributing to the Health

Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases

Primary Coenzyme Q10 Deficiency: An Update

Coenzyme Q10, Ageing and the Nervous System: An Overview

Coenzyme Q10: Clinical Applications in Cardiovascular Diseases

Coenzyme Q-10 in Human Health: Supporting Evidence?

The Use of Coenzyme Q10 in Cardiovascular Diseases

Coenzyme Q10 and Cardiovascular Diseases

Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity

Coenzyme Q10 effects in neurological diseases.

Biosynthesis, Deficiency, and Supplementation of Coenzyme Q

The Emerging Role Of Coenzyme Q-10 In Aging, Neurodegeneration, Cardiovascular Disease, Cancer And Diabetes Mellitus

Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges

Coenzyme Q10 Prevents Senescence and Dysfunction Caused by Oxidative Stress in Vascular Endothelial Cells

Coenzyme Q10 Analogues: Benefits and Challenges for Therapeutics

The Role of Coenzyme Q10 in Cardiovascular Disease Treatment: An Updated 2024 Systematic Review and Meta-Analysis of Prospective Cohort Studies (1990-2024)